D-0486-2022 Class II Terminated

Recalled by Ultra Seal Corporation — New Paltz, NY

FDA drug recall D-0486-2022 was initiated by Ultra Seal Corporation on Jan 24, 2022 and is designated Class II. Reason for recall: cGMP deviations The recall status is terminated (terminated Oct 16, 2023). Affected quantity: 301,650 packets.

Recall Details

Product Type
Drugs
Report Date
Feb 9, 2022
Initiation Date
Jan 24, 2022
Termination Date
Oct 16, 2023
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
301,650 packets

Product Description

Cold/Sinus Pain Reliever/Fever Reducer Nasal Decongestant (acetaminophen 325 mg, Phenylephrine HCl 5mg), 2 tablets per packet, Mfg, for Respond Industries and American First Aid, Mason, OH 45040

Reason for Recall

cGMP deviations

Distribution Pattern

Nationwide within the United States

Code Information

Lot #: K9708, Exp. Date 07/2022

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0486-2022
openFDA file date
Oct 26, 2026
Loaded by RegDataLab
Oct 27, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.